HOME >> MEDICINE >> NEWS
Combining osteoporosis drugs produce no added benefit

Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.

The study disproved a previously untested but widespread belief among bone researchers that combining the two types of drugs -- bone-building parathyroid hormone (PTH) and bone resorption inhibiting bisphosphonates -- should interact in a beneficial way for patients. The combination is no better than either drug alone and may even reduce the bone-building benefit, according to study results.

Black presented the findings at the American Society for Bone and Mineral Research in Minneapolis on September 20. The study results are also reported in the September 25 issue of the New England Journal of Medicine.

The randomized, double-blind trial measured the bone density of 238 postmenopausal women for one year as they took one of three daily treatments. Participants in the multi-site study took either parathyroid hormone (PTH 1-84); the bisphosphonate alendronate, marketed as Fosamax; or both. All the women began the trial with low bone mineral density.

Parathyroid hormone in the form of PTH 1-34 has been available for treatment of severe osteoporosis since its FDA approval in 2002. This trial evaluated the full-length molecule PTH 1-84 that contains 50 additional amino acids. Despite a wide-spread belief among bone researchers that bisphosphonates and parathyroid hormone would interact in a synergistic way to compound the benefit for patients, no benefit was demonstrated. Rather, the findings suggest that the concurrent use of alendronate may reduce the bone-building, or anabolic, effects of parathyroid hormone.

"We're in the early stages of use for a whole new class of bone-building medications for osteoporosis," said UCSF Professor Dennis Black, PhD, principal investigator. "These anabolic agents offer an alternative, and, with decreased reliance on estrogen,
'"/>

Contact: Eve Harris
eharris@pubaff.ucsf.edu
415-885-7277
University of California - San Francisco
20-Sep-2003


Page: 1 2 3

Related medicine news :

1. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
2. Combining hormones with external, internal radiation helps high risk prostate cancer patients
3. Combining liver transplantation and coronary artery bypass grafting can be safe and effective
4. Combining surgery with novel treatment may improve survival rates
5. Combining medication, family counseling improves treatment outcome for men who abuse heroin
6. Combining osteoporosis treatments does not produce better results
7. Combining two types of radiation therapy better for treating brain cancer
8. Study Finds Combining Exercise With Male Hormone Therapy Benefits Men With HIV-Wasting Disease
9. History of broken bones overlooked when treating osteoporosis
10. Screening for osteoporosis prevents hip fractures in older adults
11. Calcium boost to youths bones could reduce osteoporosis risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
Breaking Medicine Technology:
Cached News: